Blackrock Neurotech

Adraxe: Quality Affairs Lead

Blackrock Neurotech  •  Plymouth, MN (Onsite)  •  16 days ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

adraxe

Adraxe Corporation is an innovative medical device startup focused on the design, development, and launch of breakthrough, minimally invasive neuromodulation solutions to address unmet patient needs. The results from the first clinical epilepsy patients are encouraging and we are at the important stage of hiring key personnel, to accelerate our progress and starting our full product and clinical development. Our goal is to revolutionize neurological care with life-compatible, closed-loop neuromodulation therapies, starting with epilepsy.

The Role

The Quality Affairs Lead exists to build and own a lean, scalable Quality Management System that enables Adraxe to transition from early clinical success into full product development and commercialization of its Class III implantable neurostimulation system. This role is critical to ensuring design control rigor, DHF integrity, and regulatory readiness for IDE and eventual PMA, while effectively overseeing external partners and maintaining compliance without slowing execution. The impact is company-wide—de-risking the regulatory pathway, accelerating development timelines, and ensuring product safety and quality—directly supporting Adraxe’s mission to deliver breakthrough, minimally invasive neuromodulation therapies to patients. Success in the first 6–12 months looks like establishing a phase-appropriate QMS, achieving audit-ready design controls and risk management processes, supporting a strong IDE submission, and building the foundation for scalable quality operations and team growth.

What You'll Do

In this role, you will own and execute Adraxe’s quality strategy by building and maintaining the QMS, leading design controls and DHF integrity, and embedding risk management across product development and clinical activities. They will solve complex challenges around maintaining compliance without slowing execution, managing quality across external partners, and preparing the company for FDA scrutiny and IDE/PMA milestones. Key initiatives include QMS build-out, IDE readiness, supplier qualification and QMAs, risk management implementation, and inspection readiness, while also establishing scalable post-market systems. This role works cross-functionally with Engineering, Clinical, and Regulatory teams, partners closely with leadership, and oversees external vendors such as CDMOs, design firms, and test labs to ensure consistent quality and regulatory alignment across the program.

What You Bring

Minimum Qualifications
  • Core technical or functional competencies:
  • Deep expertise in medical device Quality Systems (QMS) and design controls for Class III devices
  • Strong working knowledge of 21 CFR Part 820, ISO 13485, and ISO 14971
  • Hands-on experience with DHF management, traceability, verification & validation
  • Supplier quality management, audits, and Quality Management Agreements (QMAs)
  • Inspection readiness, CAPA, nonconformance management, and internal auditing
  • Familiarity with IDE/PMA requirements and supporting regulatory submissions
  • Working knowledge of IEC 60601, IEC 62304, and ISO 10993
  • Relevant experience (years, domain, tools, etc.):
  • 10+ years in medical device quality or quality/regulatory or Quality Engineering roles
  • Direct experience with Class III and implantable devices (ideally neuromodulation)
  • Proven track record owning design controls and DHF in product development
  • Experience supporting IDE and/or PMA submissions
  • Strong background managing external partners (CDMOs, design firms, test labs)
  • Experience building or scaling quality systems in early-stage or fast-paced environments
Preferred Qualifications
  • Prior experience leading or mentoring quality teams:
  • Key behaviors aligned with our values
  • Ownership: Takes full accountability for quality outcomes and regulatory readiness
  • Grit: Navigates ambiguity and startup constraints while maintaining high standards
  • Curiosity: Proactively identifies gaps, asks the right questions, and continuously improves systems
  • Sound judgment: Balances compliance with speed; makes risk-based, pragmatic decisions
  • Adaptability: Thrives in a fast-evolving environment and adjusts processes as the company scales
  • Collaboration: Works effectively across functions and with external partners to drive alignment
Blackrock Neurotech

About Blackrock Neurotech

Blackrock Neurotech is a team of the world’s leading engineers, neuroscientists, and visionaries. Our mission is simple: We want people with neurological disorders to walk, talk, see, hear, and feel again. We’re engineering the next generation of neural implants, including implantable brain-computer interface technology that restores function and independence to individuals with neurological disorders. Join us in changing lives today.

Connect with us:

Join Our Team | https://bit.ly/3bCsXRv

LinkedIn | https://bit.ly/3PfifOL

Twitter | https://bit.ly/3PfifOL

Instagram | https://bit.ly/3bMaYrW

Facebook | https://bit.ly/3JRc2av

Clinical Trials | https://bit.ly/3A8QPWm

Our site | https://blackrockneurotech.com

Additional information:

As the world leader in BCI tech, our pioneering neuroscience tools push the boundaries of research and empower innovation across more than 500+ global institutional partners, restoring function in patients suffering from neurological disease (ALS, Alzheimer’s, Parkinson’s), dysfunction (epilepsy, pain, brain trauma), and paralysis disorders. Our systems can be optimized from the ground up to handle even the most challenging applications.

Our BCI is the most sophisticated and long-tested human BCI, interfacing with the brain and empowering independence in those with paralysis & other neurological disorders since 2004. In fact, dozens of patients have used our BCI for a collective 30,000+ days to regain freedom through movement and communication. Our first commercial BCI, MoveAgain, received a Breakthrough Designation from the FDA in 2021 and is expected to be commercially available in 2023.

Join us in changing lives today.

Industry
Manufacturing & Production
Company Size
51-200 employees
Headquarters
Salt Lake City, Utah
Year Founded
2008
Social Media